Asia Pacific Pain Management Devices 麻豆原创 2021-2031 by Product , Application , Mode of Purchase (Prescription, OTC), and Country: Trend Forecast and Growth Opportunity

Publication ID:

GRM0622032

Publication Date:

June 30, 2022

Pages:

Publisher:

Grace 麻豆原创 Data

Countries:

Asia Pacific [1]

USD 2,980.00

Medical Devices [2]

Country Overview (Pharma & Healthcare) [3]

Pharma & Healthcare [4]

Description:

Asia Pacific pain management devices will grow by 9.7% annually with a total addressable market cap of $16,238.7 million over 2022-2031, driven by the growing demand for chronic pain management among the geriatric population, the increasing availability of technically advanced pain management devices, supportive reimbursement policies and adverse effects of pain medications, and the growing awareness of pain management devices.
Highlighted with 33 tables and 47 figures, this 100-page report 鈥淎sia Pacific Pain Management Devices 麻豆原创 2021-2031 by Product (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps, Ablation Devices), Application (Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain, Others), Mode of Purchase (Prescription, OTC), and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Asia Pacific pain management devices market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific pain management devices market in every aspect of the classification from perspectives of Product, Application, Mode of Purchase, and Country.

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Neuromodulation & Neurostimulation Devices
o Spinal Cord Stimulators
o Transcutaneous Electrical Nerve Stimulation (TENS) Devices
o Sacral Nerve Stimulators
o Deep Brain Stimulators
o Other Neuromodulation & Neurostimulation Devices
鈥� Analgesic Infusion Pumps
o External Infusion Pumps
o Intrathecal Infusion Pumps
鈥� Ablation Devices
o Radiofrequency Ablation Devices
o Cryoablation Devices

Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Neuropathic Pain
鈥� Musculoskeletal Pain
鈥� Cancer Pain
鈥� Facial & Migraine Pain
鈥� Other Applications

By Mode of Purchase, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Prescription
鈥� Over-the-counter (OTC)

Geographically, the following national/local markets are fully investigated:
鈥� Japan
鈥� China
鈥� South Korea
鈥� Australia
鈥� India
鈥� Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Application and Mode of Purchase over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
B. Braun Melsungen AG
Baxter International Inc.
Becton, Dickinson and Company
Boston Scientific Corp.
Colfax Corporation (DJO Global LLC)
Johnson & Johnson (Codman and Shurtleff, Inc.)
Kimberly Clark Corporation
Medtronic Plc.
Nevro Corp
Pfizer, Inc.
Smiths Medical, Inc.
Stryker Corp.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of 麻豆原创 Research Methodology 10
1.2.2 麻豆原创 Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 12
1.2.6 麻豆原创 Size/Share Estimation 13
1.2.7 Research Limitations 14
1.3 Executive Summary 15
2 麻豆原创 Overview and Dynamics 17
2.1 麻豆原创 Size and Forecast 17
2.1.1 Impact of COVID-19 on World Economy 18
2.1.2 Impact of COVID-19 on the 麻豆原创 20
2.2 Major Growth Drivers 22
2.3 麻豆原创 Restraints and Challenges 28
2.4 Emerging Opportunities and 麻豆原创 Trends 31
2.5 Porter鈥檚 Fiver Forces Analysis 35
3 Segmentation of Asia Pacific 麻豆原创 by Product 39
3.1 麻豆原创 Overview by Product 39
3.2 Neuromodulation & Neurostimulation Devices 41
3.2.1 Spinal Cord Stimulators 43
3.2.2 Transcutaneous Electrical Nerve Stimulation (TENS) Devices 44
3.2.3 Sacral Nerve Stimulators 45
3.2.4 Deep Brain Stimulators 46
3.2.5 Other Neuromodulation & Neurostimulation Devices 47
3.3 Analgesic Infusion Pumps 48
3.3.1 External Infusion Pumps 49
3.3.2 Intrathecal Infusion Pumps 50
3.4 Ablation Devices 51
3.4.1 Radiofrequency Ablation Devices 52
3.4.2 Cryoablation Devices 53
4 Segmentation of Asia Pacific 麻豆原创 by Application 54
4.1 麻豆原创 Overview by Application 54
4.2 Neuropathic Pain 56
4.3 Musculoskeletal Pain 57
4.4 Cancer Pain 58
4.5 Facial & Migraine Pain 59
4.6 Other Applications 60
5 Segmentation of Asia Pacific 麻豆原创 by Mode of Purchase 61
5.1 麻豆原创 Overview by Mode of Purchase 61
5.2 Prescription 63
5.3 Over-the-counter (OTC) 64
6 Asia-Pacific 麻豆原创 2021-2031 by Country 65
6.1 Overview of Asia-Pacific 麻豆原创 65
6.2 Japan 68
6.3 China 71
6.4 Australia 73
6.5 India 75
6.6 South Korea 77
6.7 Rest of APAC Region 79
7 Competitive Landscape 81
7.1 Overview of Key Vendors 81
7.2 New Product Launch, Partnership, Investment, and M&A 84
7.3 Company Profiles 85
Abbott Laboratories 85
B. Braun Melsungen AG 87
Baxter International Inc. 88
Becton, Dickinson and Company 89
Boston Scientific Corp. 90
Colfax Corporation (DJO Global LLC) 91
Johnson & Johnson (Codman and Shurtleff, Inc.) 92
Kimberly Clark Corporation 93
Medtronic Plc. 94
Nevro Corp 95
Pfizer, Inc. 96
Smiths Medical, Inc. 97
Stryker Corp. 98
RELATED REPORTS 99

Companies Mentioned:

Selected Key Players:
Abbott Laboratories
B. Braun Melsungen AG
Baxter International Inc.
Becton, Dickinson and Company
Boston Scientific Corp.
Colfax Corporation (DJO Global LLC)
Johnson & Johnson (Codman and Shurtleff, Inc.)
Kimberly Clark Corporation
Medtronic Plc.
Nevro Corp
Pfizer, Inc.
Smiths Medical, Inc.
Stryker Corp.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.